Naltrexone (NTX) is an opioid receptor antagonist used to prevent alcoholism relapse. This trial examines how to define “non-response” to treatment with NTX and what treatments are most effective for those who do or do not respond to the initial treatment.
- PI: David Oslin
- Location: University of Pennsylvania
- Funding: NIAAA Project R01AA017164